mequinol has been researched along with hydroquinone in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (21.43) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dunn, WJ; Grigoras, S; Koehler, MG | 1 |
| Strassburg, CP; Tukey, RH | 1 |
| Kapur, S; Rosario, M; Selassie, CD; Verma, RP | 1 |
| Abellán Guillén, A; Cordeiro, MN; Garrido Escudero, A; Morales Helguera, A; Pérez-Garrido, A | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Berna, J; Garcia-Canovas, F; Garcia-Jimenez, A; Garcia-Ruiz, PA; Rodriguez-Lopez, JN; Teruel-Puche, JA; Tudela, J | 1 |
| Nair, X; Tramposch, KM | 2 |
| Barrett, GD; Chirila, TV; Constable, IJ; Thompson, DE; Walker, LN | 1 |
| Altmann, HJ; Grunow, W; Mohr, U; Wester, PW | 1 |
| Aslani, FS; Handjani, F; Kasraee, B | 1 |
| Jarratt, M | 1 |
| Chen, SP; Hongo, T; Jin, YH; Kita, K; Sumiya, Y; Sun, Z; Suzuki, N | 1 |
| Perez, MI; Rossi, AM | 1 |
1 review(s) available for mequinol and hydroquinone
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
1 trial(s) available for mequinol and hydroquinone
| Article | Year |
|---|---|
Mequinol 2%/tretinoin 0.01% solution: an effective and safe alternative to hydroquinone 3% in the treatment of solar lentigines.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Anisoles; Double-Blind Method; Drug Therapy, Combination; Face; Female; Forearm; Humans; Hydroquinones; Keratolytic Agents; Lentigo; Male; Middle Aged; Treatment Outcome; Tretinoin | 2004 |
12 other study(ies) available for mequinol and hydroquinone
| Article | Year |
|---|---|
The role of solvent-accessible surface area in determining partition coefficients.
Topics: Diffusion; Solubility; Solvents; Structure-Activity Relationship | 1987 |
Cellular apoptosis and cytotoxicity of phenolic compounds: a quantitative structure-activity relationship study.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspases; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Enzyme Activation; Mice; Molecular Conformation; Phenols; Quantitative Structure-Activity Relationship; Vinblastine | 2005 |
Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
Topics: beta-Cyclodextrins; Hydrophobic and Hydrophilic Interactions; Organic Chemicals; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Characterization of the action of tyrosinase on resorcinols.
Topics: Isomerism; Kinetics; Molecular Docking Simulation; Resorcinols; Substrate Specificity; Thermodynamics; Tyrosine | 2016 |
The Yucatan miniature swine as an in vivo model for screening skin depigmentation.
Topics: Animals; Anisoles; Catechols; Drug Evaluation, Preclinical; Female; Hydroquinones; Models, Biological; Skin; Skin Pigmentation; Swine; Swine, Miniature | 1991 |
Cytotoxic effects of residual chemicals from polymeric biomaterials for artificial soft intraocular lenses.
Topics: Anisoles; Azo Compounds; Biocompatible Materials; Cell Survival; Cells, Cultured; Choroid; Fibroblasts; Humans; Hydroquinones; L-Lactate Dehydrogenase; Lenses, Intraocular; Methacrylates; Methylmethacrylates; Nitriles | 1991 |
UVB-induced pigmentation in hairless mice as an in vivo assay for topical skin-depigmenting activity.
Topics: Animals; Anisoles; Female; Hydroquinones; Mice; Mice, Hairless; Pyrones; Skin; Skin Pigmentation; Tretinoin; Ultraviolet Rays | 1989 |
Induction of forestomach lesions by butylhydroxyanisole and structurally related substances.
Topics: Animals; Anisoles; Butylated Hydroxyanisole; Butylated Hydroxytoluene; Female; Gastric Mucosa; Hydroquinones; Hyperplasia; Male; Precancerous Conditions; Rats; Stomach Diseases; Stomach Neoplasms; Structure-Activity Relationship | 1985 |
Enhancement of the depigmenting effect of hydroquinone and 4-hydroxyanisole by all-trans-retinoic acid (tretinoin): the impairment of glutathione-dependent cytoprotection?
Topics: Animals; Anisoles; Drug Therapy, Combination; Enzyme Inhibitors; Glutathione; Glutathione Transferase; Guinea Pigs; Humans; Hydroquinones; Keratolytic Agents; Melanocytes; Skin Pigmentation; Swine; Tretinoin | 2003 |
Increase in the levels of chaperone proteins by exposure to beta-estradiol, bisphenol A and 4-methoxyphenol in human cells transfected with estrogen receptor alpha cDNA.
Topics: Anisoles; Benzhydryl Compounds; Cells, Cultured; DNA, Complementary; Endoplasmic Reticulum Chaperone BiP; Estradiol; Estrogen Receptor alpha; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; Humans; Hydroquinones; Membrane Glycoproteins; Molecular Chaperones; Phenols; Transfection | 2009 |
Treatment of hyperpigmentation.
Topics: Anisoles; Combined Modality Therapy; Dermatologic Agents; Drug Therapy, Combination; Humans; Hydroquinones; Hyperpigmentation; Keratolytic Agents; Laser Therapy; Melanosis; Retinoids | 2011 |